EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

Assessing Quality of Life in Genetic Cardiomyopathies: A Scoping Review

Lucrezia Tomberli iD, Fausto Barlocco iD, Annariina Koivu, Jari Hyttinen iD, Iacopo Olivotto, Enrica Ciucci iD

International Journal of Environmental Research and Public Health · 25.06.2026 · 23 (7) · 833

DOI: 10.3390/ijerph23070833 ↗

Kurz gefasst

Scoping Review in der Zeitschrift International Journal of Environmental Research and Public Health, online erschienen am 25.06.2026. Verfasst von Lucrezia Tomberli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Education, Languages, Intercultures, Literatures and Psychology (FORLILPSI), University of Florence, 50121 Florence, Italy. Hauptthemen laut MEDLINE: Quality of Life, Cardiomyopathies. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Florence, European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genetic cardiomyopathies (GCMs) are chronic heart muscle disorders requiring lifelong monitoring and treatment. Although quality of life (QoL) and health-related quality of life (HRQoL) are increasingly recognized as important outcomes in cardiomyopathy care, their conceptualization and measurement remain inconsistent. This scoping review aims to (a) identify the tools most commonly used to assess QoL and HRQoL in adults with genetic cardiomyopathies and (b) map the thematic areas of existing studies, including symptom burden, psychological distress, diagnostic challenges, and the impact of medical and psychological interventions. PubMed, Scopus, and PsycINFO were systematically searched, and the final search was completed in November 2025. Seventeen peer-reviewed studies met the inclusion criteria and were included in this scoping review. The review followed the PRISMA extension for Scoping Reviews and included both quantitative, qualitative and mixed-methods designs. Most studies employed standardized tools such as EQ-5D (N = 5), SF-36/SF36v2 (N = 5), and the Kansas City Cardiomyopathy Questionnaire (N = 3), while others included the Minnesota Living with Heart Failure Questionnaire (N = 2) and disease-specific or ad hoc measures. The most frequently investigated themes included impairments in physical functioning, emotional well-being, symptom burden, psychological distress, and social participation. Several studies showed that patients’ perceived QoL was more closely associated with symptom burden and psychological adjustment than with objective clinical indicators alone. Clinical interventions showed mixed or limited effects on QoL and HRQoL outcomes, even when clinical parameters improved. Qualitative research further emphasized the lived experiences of patients and families, highlighting unmet needs in care. Less commonly addressed findings concerned caregiver perspectives, patient–provider communication, treatment adherence, socioeconomic disadvantage, healthcare costs, productivity loss, and the experiences of patients with rarer cardiomyopathy-related conditions. The results highlight how QoL and HRQoL are central but still inconsistently assessed outcomes in cardiomyopathy research. This review calls for greater conceptual clarity between QoL and HRQoL, greater standardization in measurement tools, broader inclusion of psychosocial variables, and more patient-centred research approaches to better support individuals living with cardiomyopathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeCardiomyopathiesHumansSurveys and Questionnaires

Stichwörter der Autor:innen

QoL measurementsgenetic cardiomyopathyhealth related quality of lifepatient-centred approachespsychosocial factorsquality of lifewell-being

Autor:innen und Institutionen

  • Department of Education, Languages, Intercultures, Literatures and Psychology (FORLILPSI), University of Florence, 50121 Florence, Italy.
  • Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.
  • Faculty of Medicine and Health Technology, Tampere University, 33014 Tampere, Finland.

ORCID-Profile: Lucrezia Tomberli, Fausto Barlocco, Jari Hyttinen, Enrica Ciucci

Förderung

  • University of Florence
  • European Union

Zitieren

APA

Tomberli, L., Barlocco, F., Koivu, A., Hyttinen, J., Olivotto, I., & Ciucci, E. (2026). Assessing Quality of Life in Genetic Cardiomyopathies: A Scoping Review. International Journal of Environmental Research and Public Health, 23(7), 833. https://doi.org/10.3390/ijerph23070833

Vancouver

Tomberli L, Barlocco F, Koivu A, Hyttinen J, Olivotto I, Ciucci E. Assessing Quality of Life in Genetic Cardiomyopathies: A Scoping Review. International Journal of Environmental Research and Public Health. 2026;23(7):833. doi:10.3390/ijerph23070833

BibTeX
@article{Tomberli2026,
  author = {Tomberli, Lucrezia and Barlocco, Fausto and Koivu, Annariina and Hyttinen, Jari and Olivotto, Iacopo and Ciucci, Enrica},
  title = {Assessing Quality of Life in Genetic Cardiomyopathies: A Scoping Review},
  journal = {International Journal of Environmental Research and Public Health},
  year = {2026},
  volume = {23},
  number = {7},
  pages = {833},
  doi = {10.3390/ijerph23070833}
}
Kostenlos starten →